✦ LIBER ✦

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination

✍ Scribed by Rubens, R D; Knight, R K; Hayward, J L

Book ID: 109833432
Publisher: Nature Publishing Group
Year: 1975
Tongue: English
Weight: 832 KB
Volume: 32
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1975.284

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin versus methotrexate in five-d

Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial

✍ Hyman B. Muss; Douglas R. White; Frederick Richards II; M. Robert Cooper; John J 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Combination chemotherapy of advanced lun

Combination chemotherapy of advanced lung cancer. A randomized trial

✍ Heine H. Hansen; Oleg S. Selawry; Richard Simon; David T. Carr; C. E. van Wyk; R 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

Chemotherapy versus chemotherapy plus ho

Chemotherapy versus chemotherapy plus hormonotherapy in postmenopausal advanced breast cancer patients a randomized trial

✍ Pablo Viladiu; Maria Carmen Alonso; Antonio Avella; Miguel Beltrán; Juan Borrás; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

Chemotherapy versus combination of chemo

Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study

✍ G. Cocconi; V. de Lisi; C. Boni; P. Mori; P. Malacarne; D. Amadori; E. Giovanell 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Chemotherapy of advanced breast cancer:

Chemotherapy of advanced breast cancer: A randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 2 views

Advanced ovarian carcinoma: A prospectiv

Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques; J. Almeida Ricardo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

Fifty-seven evaluable patients with advanced ovarian carcinoma were randomized to receive either a combination of hexamethylmelamine, cyclophosphamide, methotrexate and 5-fluorouracil (Hexa-CAF) or high-dose cyclophosphamide alone given intravenously intermittently. Objective responses were seen in